Stroke Trials in Stockholm, Sweden
Conditions / Stroke / Stockholm, Sweden
Research into Stroke spans multiple therapeutic approaches and trial phases.
40 total trials for this combination
Showing top 10 of 40 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05679024 | Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation | RECRUITING | PHASE3 |
| NCT01225562 | Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin | COMPLETED | PHASE3 |
| NCT00153062 | PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes | COMPLETED | PHASE4 |
| NCT05284747 | EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction | ACTIVE_NOT_RECRUITING | PHASE4 |
| NCT02831608 | Study on the Effect of Influenza Vaccination After Heart Attack on Future Cardiovascular Prognosis | COMPLETED | PHASE4 |
| NCT00262600 | Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate | COMPLETED | PHASE3 |
| NCT01671007 | GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States) | COMPLETED | — |
| NCT02447081 | Amplatzer™Amulet™ Post-Market Study (Amulet™PMS) | COMPLETED | — |
| NCT00044915 | Repinotan in Patients With Acute Ischemic Stroke | COMPLETED | PHASE2 |
| NCT02239120 | Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS) | COMPLETED | PHASE3 |